USE OF AN LTB4 ANTAGONIST FOR THE TREATMENT AND/OR PREVENTION OF DISEASES CAUSED BY INCREASED EXPRESSION OF MUCIN GENES

Details for Australian Patent Application No. 2002246035 (hide)

Owner BOEHRINGER INGELHEIM PHARMA KG

Inventors MEADE, Christopher, John, Montague; BIRKE, Franz; JENNEWEIN, Hans, Michael; JUNG, Birgit; ANDERSKEWITZ, Ralf

Pub. Number AU-A-2002246035

PCT Pub. Number WO2002/055065

Priority 0101128.7 16.01.01 GB; 60/266,833 06.02.01 US

Filing date 15 January 2002

Wipo publication date 24 July 2002

International Classifications

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61P 011/12 Drugs for disorders of the respiratory system

A61P 011/00 Drugs for disorders of the respiratory system

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002246035

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246036-BASIC SUSPENSION, ITS PREPARATION AND PROCESS FOR PAPER DEACIDIFICATION

2002246034-HETEROGENICALLY CATALYSED GAS-PHASE PARTIAL OXIDATION METHOD FOR PRECURSOR COMPOUNDS OF (METH)ACRYLIC ACID